CD40 and neoplasm: A similar pattern was evident when patients were subgrouped according to TNM7 stage, with no differences being evident for RelA and P100/P52 expression across tumor stages and with increased P50 and RelB expression in stage III patients compared with stage I/II patients (Figure 3).